Literature DB >> 1357708

Kappa opioid receptor activity modulates memory for peck-avoidance training in the 2-day-old chick.

P J Colombo1, J L Martinez, E L Bennett, M R Rosenzweig.   

Abstract

To examine the role of kappa opioid receptors in memory formation, 2-day-old chicks were injected intracerebrally with either the endogenous opioid peptide dynorphin(1-13), the highly kappa selective agonist U-50,488 or the kappa selective antagonist nor-binaltorphimine (nor-BNI), given one-trial peck-avoidance training, and tested 24 h later. Dynorphin(1-13) impaired memory in a dose dependent manner at 24 h test. Injection of U-50,488 caused a biphasic dose-dependent effect on memory; low doses caused a trend toward enhanced memory and high doses caused significant impairment. Conversely, injection of low doses of nor-BNI caused a trend toward memory impairment, and higher doses caused significant memory enhancement. The results indicate that memory formation for one-trial peck-avoidance training may be modulated by kappa opioid receptor activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357708     DOI: 10.1007/bf02245314

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Naloxone enhancement of memory.

Authors:  R B Messing; R A Jensen; J L Martinez; V R Spiehler; B J Vasquez; B Soumireu-Mourat; K C Liang; J L McGaugh
Journal:  Behav Neural Biol       Date:  1979-11

2.  Naloxone enhancement of memory processes: effects of other opiate antagonists.

Authors:  M Gallagher
Journal:  Behav Neural Biol       Date:  1982-08

3.  Enkephalins interfere with acquisition of an active avoidance response.

Authors:  H Rigter; T J Hannan; R B Messing; J L Martinez; B J Vasquez; R A Jensen; J Veliquette; J L McGaugh
Journal:  Life Sci       Date:  1980-02-04       Impact factor: 5.037

4.  Effects of a low and a high dose of beta-endorphin on acquisition and retention in the rat.

Authors:  I Izquierdo
Journal:  Behav Neural Biol       Date:  1980-12

5.  Enkephalin and a potent analog facilitate maze performance after intraperitoneal administration in rats.

Authors:  A J Kastin; E L Scollan; M G King; A V Schally; D H Coy
Journal:  Pharmacol Biochem Behav       Date:  1976-12       Impact factor: 3.533

6.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

Authors:  P F Vonvoigtlander; R A Lahti; J H Ludens
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

7.  Passive avoidance training results in lasting changes in deoxyglucose metabolism in left hemisphere regions of chick brain.

Authors:  S P Rose; A Csillag
Journal:  Behav Neural Biol       Date:  1985-09

8.  Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.

Authors:  P S Portoghese; A W Lipkowski; A E Takemori
Journal:  Life Sci       Date:  1987-03-30       Impact factor: 5.037

9.  Enkephalin actions on avoidance conditioning may be related to adrenal medullary function.

Authors:  J L Martinez; H Rigter
Journal:  Behav Brain Res       Date:  1982-11       Impact factor: 3.332

10.  Behavioral effects of dynorphin 1-13 in the mouse and rat: initial observations.

Authors:  J M Walker; R J Katz; H Akil
Journal:  Peptides       Date:  1980       Impact factor: 3.750

View more
  7 in total

1.  Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against various Gi-protein alpha subunits.

Authors:  N Galeotti; C Ghelardini; A Bartolini
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 2.  Role of kappa-opioid receptors in stress and anxiety-related behavior.

Authors:  Ashlee Van't Veer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

3.  Inhibition of passive-avoidance memory formation in the day-old chick by the opioid cytochrophin-4.

Authors:  F M Freeman; I G Young
Journal:  Learn Mem       Date:  2000 Jul-Aug       Impact factor: 2.460

4.  Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.

Authors:  Jason J Paris; Kate J Reilley; Jay P McLaughlin
Journal:  J Addict Res Ther       Date:  2011-12-24

Review 5.  Dynorphin, stress, and depression.

Authors:  Allison T Knoll; William A Carlezon
Journal:  Brain Res       Date:  2009-09-24       Impact factor: 3.252

6.  Improvement by dynorphin A (1-13) of galanin-induced impairment of memory accompanied by blockade of reductions in acetylcholine release in rats.

Authors:  M Hiramatsu; H Mori; H Murasawa; T Kameyama
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

7.  A functional polymorphism in the prodynorphin gene affects cognitive flexibility and brain activation during reversal learning.

Authors:  Mikhail Votinov; Juergen Pripfl; Christian Windischberger; Ewald Moser; Uta Sailer; Claus Lamm
Journal:  Front Behav Neurosci       Date:  2015-07-03       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.